These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29117939)

  • 21. Epidermal Growth Factor (EGF) Augments the Invasive Potential of Human Glioblastoma Multiforme Cells via the Activation of Collaborative EGFR/ROS-Dependent Signaling.
    Pudełek M; Król K; Catapano J; Wróbel T; Czyż J; Ryszawy D
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
    Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
    Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of TROY/TNFRSF19/TAJ-expressing cells in the adult mouse forebrain.
    Hisaoka T; Morikawa Y; Senba E
    Brain Res; 2006 Sep; 1110(1):81-94. PubMed ID: 16870160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFR Signals through a DOCK180-MLK3 Axis to Drive Glioblastoma Cell Invasion.
    Misek SA; Chen J; Schroeder L; Rattanasinchai C; Sample A; Sarkaria JN; Gallo KA
    Mol Cancer Res; 2017 Aug; 15(8):1085-1095. PubMed ID: 28487380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
    Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
    Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mechanism for the upregulation of EGF receptor levels in glioblastomas.
    Zhang J; Antonyak MA; Singh G; Cerione RA
    Cell Rep; 2013 Jun; 3(6):2008-20. PubMed ID: 23770238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
    Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
    Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
    von Achenbach C; Weller M; Szabo E
    J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined EGFR and autophagy modulation impairs cell migration and enhances radiosensitivity in human glioblastoma cells.
    Palumbo S; Tini P; Toscano M; Allavena G; Angeletti F; Manai F; Miracco C; Comincini S; Pirtoli L
    J Cell Physiol; 2014 Nov; 229(11):1863-73. PubMed ID: 24691646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
    Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated Insights on EGFR Signaling Pathways in Glioma.
    Oprita A; Baloi SC; Staicu GA; Alexandru O; Tache DE; Danoiu S; Micu ES; Sevastre AS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
    Wang F; Xiao W; Sun J; Han D; Zhu Y
    Tumour Biol; 2014 Sep; 35(9):8653-8. PubMed ID: 24867100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
    Di K; Linskey ME; Bota DA
    Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
    Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
    Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma.
    Nadeem Abbas M; Kausar S; Wang F; Zhao Y; Cui H
    Cells; 2019 Apr; 8(4):. PubMed ID: 31013819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
    Spanjaard RA; Whren KM; Graves C; Bhawan J
    Int J Cancer; 2007 Mar; 120(6):1304-10. PubMed ID: 17187358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
    Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
    Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma.
    Areeb Z; Stuart SF; West AJ; Gomez J; Nguyen HPT; Paradiso L; Zulkifli A; Jones J; Kaye AH; Morokoff AP; Luwor RB
    Sci Rep; 2020 Oct; 10(1):17768. PubMed ID: 33082482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.